Metabolic regulation and dysregulation of endothelial small conductance calcium activated potassium channels.


Journal

European journal of cell biology
ISSN: 1618-1298
Titre abrégé: Eur J Cell Biol
Pays: Germany
ID NLM: 7906240

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 27 12 2021
revised: 06 02 2022
accepted: 07 02 2022
pubmed: 14 2 2022
medline: 10 5 2022
entrez: 13 2 2022
Statut: ppublish

Résumé

The vascular endothelium is an important regulator of vascular reactivity and preserves the balance between vasoconstrictor and vasodilator tone during normal physiologic conditions. Example endothelial-derived vasoconstrictors include endothelin-1 and thromboxane A2; example vasodilators include nitric oxide and prostacyclin. A growing body of evidence points to the existence of a non-nitric oxide, non-prostacyclin endothelium-derived vasodilatory factor of currently unclear identity, often referred to as endothelium-derived hyperpolarizing factor (EDHF). Recent research testifies to the significance of EDHF in endothelium-dependent vascular smooth muscle relaxation. Special emphasis has been placed on the role of small conductance calcium-activated potassium channels (SK) in facilitating the endothelial and vascular responses to EDHF across the microcirculation, including coronary, mesenteric, and pulmonary vascular beds. Meanwhile, decreased activity of endothelial SK channel activity has been implicated in the pathology of a variety of disease states that alter the balance between vasodilator and vasoconstrictor tone. Hence the primary goal of this review is to characterize the physiology of endothelial SK channels in the microvasculature under normal and pathological conditions. Themes of regulation and dysregulation of SK channel activity through the action of protein kinases, reactive oxygen species, and byproducts of intermediary metabolism provide unifying principles to tie together vascular pathology in altered metabolic states ranging from hypertension to diabetes, to ischemia-reperfusion. A comprehensive understanding of SK channel pathophysiology may provide a foundation for development of new therapeutics targeting SK channels, particularly SK channel potentiators, that may have widespread application for many chronic disease states.

Identifiants

pubmed: 35151983
pii: S0171-9335(22)00011-5
doi: 10.1016/j.ejcb.2022.151208
pii:
doi:

Substances chimiques

Biological Factors 0
Small-Conductance Calcium-Activated Potassium Channels 0
Vasoconstrictor Agents 0
Vasodilator Agents 0
endothelium-dependent hyperpolarization factor 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

151208

Informations de copyright

Copyright © 2022. Published by Elsevier GmbH.

Auteurs

Shawn Kant (S)

Division of Cardiothoracic Surgery, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, USA.

Frank Sellke (F)

Division of Cardiothoracic Surgery, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, USA.

Jun Feng (J)

Division of Cardiothoracic Surgery, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, USA. Electronic address: jfeng@lifespan.org.

Articles similaires

Animals Male Antioxidants Rats, Wistar Rats
Humans beta-Thalassemia Oxidative Stress Male Female

[Estrogen receptors and vascular aging].

Juline Marjollet, Mélissa Buscato, Morgane Davezac et al.
1.00
Humans Aging Female Receptors, Estrogen Cardiovascular Diseases

Classifications MeSH